CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2013—Randox’s two new controls, Acusera Liquid Assayed Chemistry Premium and Premium Plus, are designed to drastically cut the number of individual quality controls a laboratory needs to run in routine medical testing while providing clinically significant values for a wide range of analyzers at key decision points.
The Acusera Chemistry Premium Plus control contains 100 analytes, and the Acusera Chemistry Premium control offers 91. Their comprehensive combination of lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs, routine chemistry analytes, and high levels of CRP and other key proteins eliminate the need for multiple controls, streamlining QC in laboratories.
Both controls are liquid for ease of use, eliminating possible reconstitution errors and improving lab efficiency. Available in low-, mid-, and high-concentration levels, Premium Plus covers the full clinical range, removing the need for laboratories to purchase additional low- or high-level controls.
The controls are highly stable when stored at -20˚C to -70˚C, with open-vial stability of seven days at 2˚C to 8˚C. Manufactured using human-based serum, these third-party controls ensure unbiased, independent assessment of analytical performance.
The controls are now available in the United Kingdom, Europe, Middle East, Far East, and Africa. Randox is awaiting product approval from the FDA and China’s SFDA.
Randox, 44 (0) 28 9442 2413